Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient

Int J Infect Dis. 2015 May:34:122-5. doi: 10.1016/j.ijid.2015.03.019. Epub 2015 Mar 30.

Abstract

We report herein a case of bacteremic ascitic fluid infection in a liver transplant patient caused by a strain of Yersinia pseudotuberculosis serogroup I that lost the yersiniabactin core. The patient's outcome was favorable after a combined therapy with a third-generation cephalosporin and gentamicin.

Keywords: Ascitic fluid infection; Bacteremia; Hepatic cirrhosis; Liver transplant; Third-generation cephalosporin; Yersinia pseudotuberculosis.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Ascitic Fluid / microbiology*
  • Bacteremia / diagnosis*
  • Bacteremia / drug therapy
  • Bacteremia / etiology
  • Cephalosporins / therapeutic use
  • Drug Therapy, Combination
  • Gentamicins / therapeutic use
  • Humans
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Treatment Outcome
  • Yersinia pseudotuberculosis / isolation & purification*
  • Yersinia pseudotuberculosis Infections / diagnosis*
  • Yersinia pseudotuberculosis Infections / drug therapy

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Gentamicins